Susan Halsey, Psyd, Pllc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9 Long Pond Rd, Waccabuc, NY 10597 Phone: 914-621-8989 |
News Archive
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
iCAD, Inc., which designs, develops and markets Computer Aided Detection (CAD) imaging technology and systems for the early detection of breast cancer and other medical applications, today announced that the U.S. Patent and Trademark Office has issued the Company two patents for its Fulcrum mammography film digitizer and technology.
Canada's ranking in international child health indexes would dramatically improve if measurements were standardized, according to a new study by researchers from the University of British Columbia, Dalhousie University, McGill University, the University of Calgary, and the Public Health Agency of Canada, working with the Canadian Perinatal Surveillance System and funded by the Canadian Institutes of Health Research (CIHR).
Results from a Korean study show that the symptom structure of second-generation-antipsychotic-induced obsessive compulsive symptoms is similar to that seen in patients with "pure" obsessive compulsive disorder.
› Verified 1 days ago